characteristics | n (%) | |
---|---|---|
sex | male | 29 (53%) |
female | 26 (47%) | |
stage | I | 13 (24%) |
II | 28 (51%) | |
III | 14 (25%) | |
B symptoms | 16 (29%) | |
risk factors | a | 0 (0%) |
b | 1 (2%) | |
c | 13 (24%) | |
d | 10 (18%) | |
histology | lymphocyte-predominant | 7 (13%) |
nodular sclerosing | 36 (65%) | |
mixed | 10 (18%) | |
not available | 2 (4%) | |
involved regions | cervical | 27 (49%) |
supra-/infraclavicular | 31 (56.4%) | |
axilla | 13 (23,7%) | |
mediastinum | 30 (54.5%) | |
paraaortic | 2 (4%) | |
inguinal | 3 (5%) | |
spleen | 11 (20%) | |
treatment | radiotherapy alone | 33 (60%) |
chemoradiation | 22 (40%) |